ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
rdf:type |
tido:PieceOfInformation |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV007 |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEABC7D27C0BF8128FA |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEABC7D27C0BF8128FA |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
ripe:rationale |
No concerns. |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |